Mabxience S.A., headquartered in Switzerland, is a prominent player in the biopharmaceutical industry, specialising in the development and manufacturing of biosimilars and innovative biologics. Founded in 2015, the company has rapidly established itself in key operational regions across Europe and Latin America, focusing on enhancing patient access to high-quality therapies. Mabxience's core offerings include a range of biosimilars that are distinguished by their rigorous quality standards and commitment to affordability. The company has achieved significant milestones, including successful product launches and partnerships that bolster its market position. With a dedication to research and development, Mabxience continues to contribute to the evolving landscape of biopharmaceuticals, ensuring that patients receive effective and accessible treatment options.
We don't have data for Mabxience S.A., but we can show you information about their parent organization instead.
View parent company